Abstract:Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses.Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production.Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.

DEAD-box RNA Helicase DDX3X Inhibits DENV Replication Via Regulating Type One Interferon Pathway

DEAD-Box Helicase DDX25 is a Negative Regulator of Type I Interferon Pathway and Facilitates RNA Virus Infection

DDX50 Inhibits the Replication of Dengue Virus 2 by Upregulating IFN-β Production

DDX20 positively regulates the interferon pathway to inhibit viral infection

DEAD-box RNA helicase 18 disrupts IRF3-binding to the interferon-β promoter

DEAD-box RNA helicase 21 negatively regulates cytosolic RNA-mediated innate immune signaling

DEAD-Box Helicase DDX6 Facilitated RIG-I-Mediated Type-I Interferon Response to EV71 Infection.

DDX56 Inhibits Type I Interferon by Disrupting Assembly of IRF3–IPO5 to Inhibit IRF3 Nucleus Import

The DEAD-Box RNA Helicase DDX1 Interacts with the Viral Protein 3D and Inhibits Foot-and-Mouth Disease Virus Replication

DDX21 translocates from nucleus to cytoplasm and stimulates the innate immune response due to dengue virus infection

DDX3X Coordinates Host Defense Against Influenza Virus by Activating the NLRP3 Inflammasome and Type I Interferon Response

DDX56 Antagonizes IFN-β Production to Enhance EMCV Replication by Inhibiting IRF3 Nuclear Translocation

Molecular Cloning and Functional Characterization of Duck DEAD (Asp-Glu-ala-asp) Box RNA Helicase 3 (DDX3X)

Protein Kinase Regulated By Dsrna Downregulates The Interferon Production In Dengue Virus- And Dsrna-Stimulated Human Lung Epithelial Cells

DDX21, a Host Restriction Factor of FMDV IRES-Dependent Translation and Replication

Interferon-stimulated TRIM69 interrupts dengue virus replication by ubiquitinating viral nonstructural protein 3.

Chicken DDX3X Activates IFN-β Via the Chsting-Chirf7-ifn-β Signaling Axis

DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation

Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection

The DEAD box RNA helicase DDX3X is required in natural killer cells

Caspase-Dependent Cleavage of DDX21 Suppresses Host Innate Immunity